|
SF3A1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.64173144365532E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.92269533627609E-11 |
| Normal-vs-Stage2 |
2.188500E-04 |
| Normal-vs-Stage3 |
2.03159999999647E-05 |
| Normal-vs-Stage4 |
3.02610000391113E-08 |
| Stage1-vs-Stage2 |
8.404400E-01 |
| Stage1-vs-Stage3 |
9.569200E-01 |
| Stage1-vs-Stage4 |
2.244800E-01 |
| Stage2-vs-Stage3 |
8.798600E-01 |
| Stage2-vs-Stage4 |
2.970000E-01 |
| Stage3-vs-Stage4 |
3.704000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.06730188523352E-11 |
| Normal-vs-AfricanAmerican |
6.52760068220459E-11 |
| Normal-vs-Asian |
1.15129999977981E-07 |
| Caucasian-vs-AfricanAmerican |
4.334600E-01 |
| Caucasian-vs-Asian |
2.100000E-01 |
| AfricanAmerican-vs-Asian |
1.625390E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.00683913931243E-12 |
| Normal-vs-Female |
7.94090000000303E-05 |
| Male-vs-Female |
6.896000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.95130000835553E-09 |
| Normal-vs-Extreme_Weight |
5.99870153550341E-11 |
| Normal-vs-Obese |
4.5845999999683E-06 |
| Normal-vs-Extreme_Obese |
6.382600E-03 |
| Normal_Weight-vs-Extreme_Weight |
7.870000E-01 |
| Normal_Weight-vs-Obese |
6.769500E-02 |
| Normal_Weight-vs-Extreme_Obese |
8.130400E-01 |
| Extreme_Weight-vs-Obese |
8.057800E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.406000E-01 |
| Obese-vs-Extreme_Obese |
4.011400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.264200E-03 |
| Normal-vs-Age(41-60Yrs) |
2.3622000022705E-08 |
| Normal-vs-Age(61-80Yrs) |
3.69748676121162E-12 |
| Normal-vs-Age(81-100Yrs) |
7.48960005125809E-09 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.955400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.845200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.082750E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.562610E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.184010E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.986400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.1905000036071E-10 |
| Normal-VS-Type2 PRCC |
2.49755771619675E-12 |
| Normal-VS-KIRP CIMP |
7.950400E-02 |
| Normal-VS-Unclassified PRCC |
2.988200E-04 |
| Type1 PRCC-VS-Type2 PRCC |
9.389800E-02 |
| Type1 PRCC-VS-KIRP CIMP |
4.548000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.151000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.472300E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
7.276200E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
6.454000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.52460291455736E-12 |
| Normal-vs-N1 |
2.644900E-03 |
| Normal-vs-N2 |
1.304090E-03 |
| N0-vs-N1 |
8.617700E-02 |
| N0-vs-N2 |
5.609000E-01 |
| N1-vs-N2 |
7.950800E-01 |
|
|
